Evidence map›Paper›PMID 34231244›Full record

ArticleAnnals of neurology2021

Automated Annotation of Epileptiform Burden and Its Association with Outcomes.

Sahar F Zafar, Eric S Rosenthal, Jin Jing, Wendong Ge, Mohammad Tabaeizadeh, Hassan Aboul Nour, Maryum Shoukat, Haoqi Sun, Farrukh Javed, Solomon Kassa and 10 more

Abstract read
In one paragraph

Article in Annals of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Article
  3. Resting-state EEG for continuous prognostic monitoring and prediction of coma recovery after acute brain injury.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Using artificial intelligence to optimize anti-seizure treatment and EEG-guided decisions in severe brain injury.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. The Cost of After-Hour Electroencephalography.Neurology. Clinical practice · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sahar F Zafar *Department of Neurology, Massachusetts General Hospital, Boston, MA.ORCID 0000-0001-5252-5376
Eric S Rosenthal *Department of Neurology, Massachusetts General Hospital, Boston, MA.ORCID 0000-0003-3900-356X
Jin Jing *Department of Neurology, Massachusetts General Hospital, Boston, MA.
Wendong Ge *Department of Neurology, Massachusetts General Hospital, Boston, MA.
Mohammad TabaeizadehDepartment of Neurology, Massachusetts General Hospital, Boston, MA.
Hassan Aboul NourDepartment of Neurology, Massachusetts General Hospital, Boston, MA.ORCID 0000-0002-6698-5848
Maryum ShoukatDepartment of Neurology, Massachusetts General Hospital, Boston, MA.ORCID 0000-0003-0571-6633
Haoqi SunDepartment of Neurology, Massachusetts General Hospital, Boston, MA.
Farrukh JavedDepartment of Neurology, Massachusetts General Hospital, Boston, MA.
Solomon KassaDepartment of Neurology, Massachusetts General Hospital, Boston, MA.
Muhammad EdhiDepartment of Neurology, Massachusetts General Hospital, Boston, MA.
Elahe BordbarDepartment of Neurology, Temple University, Philadelphia, PA.
Justin GallagherDepartment of Neurology, Massachusetts General Hospital, Boston, MA.
Valdery MouraDepartment of Neurology, Massachusetts General Hospital, Boston, MA.
Manohar GhantaDepartment of Neurology, Massachusetts General Hospital, Boston, MA.
Yu-Ping ShaoDepartment of Neurology, Massachusetts General Hospital, Boston, MA.
Sungtae AnGeorgia Institute of Technology, College of Computing, Atlanta, GA.
Jimeng SunUniversity of Illinois, Champaign, IL.
Andrew J ColeDepartment of Neurology, Massachusetts General Hospital, Boston, MA.ORCID 0000-0002-0828-826X
M Brandon WestoverDepartment of Neurology, Massachusetts General Hospital, Boston, MA.ORCID 0000-0003-4803-312X

Funding

Integrative Motor Activity Biomarker for the Risk of Alzheimer's RiskRF1AG064312 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI HU, KUN · 2019 to 2019
$3.6M
Multimodal Network Connectivity Architecture (MOCA) of the Brain and its Role in the Recovery of Consciousness in Comatose Cardiac Arrest PatientsR01NS102574 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI GREER, DAVID MATTHEW, WU, ONA · 2018 to 2022
$3.4M
Investigation of Sleep in the Intensive Care Unit (ICU-SLEEP)R01NS102190 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI WESTOVER, MICHAEL BRANDON · 2018 to 2022
$3.2M
Big Data and Deep Learning for the Interictal-Ictal-Injury ContiuumR01NS107291 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI WESTOVER, MICHAEL BRANDON · 2018 to 2022
$2.8M
Real-Time Prediction of Delayed Cerebral Ischemia after Subarachnoid HemorrhageK23NS105950 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENTHAL, ERIC S. · 2018 to 2022
$1.0M
Optimizing anti-epileptic drug treatment in acute brain injuryK23NS114201 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ZAFAR, SAHAR F · 2019 to 2023
$1.0M
NIA NIH HHS RF1 AG064312NINDS NIH HHS 1R01NS10NINDS NIH HHS 1R01NS102190NINDS NIH HHS 1R01NS102574NINDS NIH HHS K23 NS105950NINDS NIH HHS K23NS105950NINDS NIH HHS K23 NS114201NINDS NIH HHS K23NS114201NINDS NIH HHS R01 NS102190NINDS NIH HHS R01 NS102574NINDS NIH HHS R01 NS107291Sage Therapeutics
6 · The paper itself

Abstract

objectiveThis study was undertaken to determine the dose-response relation between epileptiform activity burden and outcomes in acutely ill patients.

methodsA single center retrospective analysis was made of 1,967 neurologic, medical, and surgical patients who underwent >16 hours of continuous electroencephalography (EEG) between 2011 and 2017. We developed an artificial intelligence algorithm to annotate 11.02 terabytes of EEG and quantify epileptiform activity burden within 72 hours of recording. We evaluated burden (1) in the first 24 hours of recording, (2) in the 12-hours epoch with highest burden (peak burden), and (3) cumulatively through the first 72 hours of monitoring. Machine learning was applied to estimate the effect of epileptiform burden on outcome. Outcome measure was discharge modified Rankin Scale, dichotomized as good (0-4) versus poor (5-6).

resultsPeak epileptiform burden was independently associated with poor outcomes (p < 0.0001). Other independent associations included age, Acute Physiology and Chronic Health Evaluation II score, seizure on presentation, and diagnosis of hypoxic-ischemic encephalopathy. Model calibration error was calculated across 3 strata based on the time interval between last EEG measurement (up to 72 hours of monitoring) and discharge: (1) <5 days between last measurement and discharge, 0.0941 (95% confidence interval [CI] = 0.0706-0.1191); 5 to 10 days between last measurement and discharge, 0.0946 (95% CI = 0.0631-0.1290); >10 days between last measurement and discharge, 0.0998 (95% CI = 0.0698-0.1335). After adjusting for covariates, increase in peak epileptiform activity burden from 0 to 100% increased the probability of poor outcome by 35%.

interpretationAutomated measurement of peak epileptiform activity burden affords a convenient, consistent, and quantifiable target for future multicenter randomized trials investigating whether suppressing epileptiform activity improves outcomes. ANN NEUROL 2021;90:300-311.

Indexed as

Artificial IntelligenceCost of IllnessAgedCohort StudiesElectroencephalographyFemaleHumansMaleMiddle AgedRetrospective StudiesSeizuresTreatment Outcome

Identifiers

PMID34231244
PMCPMC8516549

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.